PDE4A and chronic obstructive pulmonary disease: Thus, conceptually, the high level of inflammation seen in severe COPD with chronic bronchitis phenotype may be more responsive to an inhaled glucocorticoid and a PDE4 inhibitor if used together (Giembycz and Newton, 2015).